Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Lucas

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Genome Biology and Evolution|March 28, 2023
Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging VariantsMary E Petrone, Carolina Lucas, Bridget Menasche, et al.
The Journal of Experimental Medicine|November 10, 2021
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in miceTianyang Mao, Benjamin Israelow, Carolina Lucas, et al.
Nature Communications|March 9, 2023
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunityJillian R Jaycox, Carolina Lucas, Inci Yildirim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccineLuciana Conde, Valter Monteiro, Joao Cr Freitas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Kynurenic acid underlies sex-specific immune responses to COVID-19Yuping Cai, Daniel J Kim, Takehiro Takahashi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Sex differences in symptomatology and immune profiles of Long COVIDJulio Silva, Takehiro Takahashi, Jamie Wood, et al.
Science Signaling|July 7, 2021
Kynurenic acid may underlie sex-specific immune responses to COVID-19Yuping Cai, Daniel J Kim, Takehiro Takahashi, et al.
The Lancet. Infectious Diseases|June 18, 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational studyJameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, et al.
Nature|October 11, 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Chantal B F Vogels, Inci Yildirim, et al.
Science Immunology|May 5, 2023
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditisAnis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Genome Biology and Evolution|March 28, 2023
Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging VariantsMary E Petrone, Carolina Lucas, Bridget Menasche, et al.
The Journal of Experimental Medicine|November 10, 2021
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in miceTianyang Mao, Benjamin Israelow, Carolina Lucas, et al.
Nature Communications|March 9, 2023
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunityJillian R Jaycox, Carolina Lucas, Inci Yildirim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccineLuciana Conde, Valter Monteiro, Joao Cr Freitas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Kynurenic acid underlies sex-specific immune responses to COVID-19Yuping Cai, Daniel J Kim, Takehiro Takahashi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Sex differences in symptomatology and immune profiles of Long COVIDJulio Silva, Takehiro Takahashi, Jamie Wood, et al.
Science Signaling|July 7, 2021
Kynurenic acid may underlie sex-specific immune responses to COVID-19Yuping Cai, Daniel J Kim, Takehiro Takahashi, et al.
The Lancet. Infectious Diseases|June 18, 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational studyJameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, et al.
Nature|October 11, 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Chantal B F Vogels, Inci Yildirim, et al.
Science Immunology|May 5, 2023
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditisAnis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Pageof 6